中安科股份有限公司关于2023年股票期权与限制性股票激励计划2025年第四季度自主行权结果暨股份变动公告

Core Viewpoint - The announcement details the results of the stock option and restricted stock incentive plan for the fourth quarter of 2025, highlighting the number of shares exercised and the overall participation in the plan. Group 1: Stock Option Exercise Results - In the fourth quarter of 2025, a total of 1,170,480 shares were exercised under the second exercise period of the incentive plan, accounting for 60.96% of the total options available for exercise during this period [2] - By the end of the fourth quarter of 2025, the cumulative number of shares exercised and registered under the second exercise period reached 1,883,021 shares, representing 98.07% of the total options available for this period [2] - The shares obtained through the exercise will be listed for trading on the second trading day after the exercise date (T+2) [2] Group 2: Decision-Making Process and Disclosure - The decision-making process for the incentive plan was approved by the board of directors on March 17, 2023, with independent directors providing their consent and legal opinions being issued [3][4] - The company publicly disclosed the names and positions of the incentive plan participants from March 18 to March 27, 2023, with no objections received during the public notice period [3] - The first grant of stock options and restricted stocks was approved on April 3, 2023, with a total of 65.5 million stock options and restricted stocks granted [4][5] Group 3: Stock Option and Restricted Stock Details - The stock options granted were priced at 2.00 CNY per share, while the restricted stocks were priced at 1.25 CNY per share [5] - The registration of stock options and restricted stocks was completed on June 1 and June 19, 2023, respectively, with 10.05 million stock options and 53.32 million restricted stocks registered [5][6] - The company has conducted buybacks of restricted stocks for individuals who have left the company, with specific numbers detailed in subsequent announcements [6][9] Group 4: Financial Impact and Fund Utilization - The funds raised from the exercise of stock options in the fourth quarter of 2025 amounted to 2,340,960 CNY, which will be used to supplement the company's working capital [16] - The exercise of stock options is not expected to have a significant impact on the company's financial status or operating results [17]